Panic early in the pandemic eventually shifted to optimism, as investors threw capital at stocks involved in remote activities including work, healthcare, exercise, and shopping. Novo Nordisk Pharmaceutical stock Novo Nordisk (NYSE: NVO) is up more than 55% this year. It was a wild year in the market as investors juggled ongoing pandemic recovery, inflation, monetary policy, high valuations, and geopolitical issues.